Brief: Landos Biopharma Says Tim Mayleben, Who Has Been Serving As Interim President And CEO Since Nov 2021, Will Continue To Serve As Member Of Company's Board

Landos Biopharma

21/06/2022 14:44

June 21 (Reuters) - Landos Biopharma Inc  LABP.O :
    * LANDOS NAMES GREGORY OAKES PRESIDENT AND CHIEF EXECUTIVE
OFFICER
    * LANDOS BIOPHARMA-TIM MAYLEBEN, WHO HAS BEEN SERVING AS
INTERIM
PRESIDENT AND CEO SINCE NOV 2021, WILL CONTINUE TO SERVE AS
MEMBER OF COMPANY'S BOARD
    * LANDOS - OAKES HAS BEEN NAMED PRESIDENT AND CHIEF
EXECUTIVE
OFFICER, AND HAS BEEN APPOINTED TO LANDOS BOARD OF DIRECTORS,
EFFECTIVE IMMEDIATELY

Source text for Eikon:  ID:nGNX8tgkNR 
Further company coverage:  LABP.O